CAMP4 Therapeutics
CAMP
CAMP
39 hedge funds and large institutions have $50.7M invested in CAMP4 Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.88% less ownership
Funds ownership: 63.76% → 62.88% (-0.88%)
24% less capital invested
Capital invested by funds: $67.1M → $50.7M (-$16.4M)
Holders
39
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$184K | |
| 2 | +$123K | |
| 3 | +$77.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$58.1K |
| 5 |
Bank of New York Mellon
New York
|
+$52.5K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$176K | |
| 3 | -$52.8K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$52.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$28.5K |
